insulin glulisine

FDA Drug Profile — Apidra, Apidra SoloStar

Drug Details

Generic Name
insulin glulisine
Brand Names
Apidra, Apidra SoloStar
Application Number
BLA021629
Sponsor
sanofi-aventis U.S. LLC
NDC Codes
2
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAVENOUS, SUBCUTANEOUS
Active Ingredients
INSULIN GLULISINE

Indications and Usage

1 INDICATIONS AND USAGE APIDRA is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. APIDRA is a rapid-acting human insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus. ( 1 )